Rybelsus® (Semaglutide) Tablets
Rybelsus® (semaglutide) is the first oral GLP-1 receptor agonist approved for adults with type 2 diabetes. Taken once daily, it improves glycaemic control and may support weight reduction, offering a convenient alternative to injectable GLP-1 therapies.
What Is Rybelsus Used For?
Rybelsus contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for improving blood glucose control in adults with type 2 diabetes mellitus.
- Enhances glycaemic control alongside diet and exercise
- May contribute to weight reduction as a secondary benefit
- Provides an oral alternative to injectable semaglutide products
For full prescribing details, consult the official Rybelsus Product Monograph.
How Rybelsus Works
Semaglutide mimics the natural GLP-1 hormone and works through several complementary mechanisms:
- Stimulates insulin release when blood glucose levels are elevated
- Suppresses glucagon secretion from the liver
- Delays gastric emptying, helping prolong satiety
- Reduces appetite via central nervous system pathways
These combined effects improve HbA1c levels and may support gradual, sustainable weight management when paired with lifestyle measures.
Dosage and Administration
Standard Dosing Schedule
- Initial dose: 3 mg once daily for 30 days (for tolerability; not for glycaemic control)
- Step-up dose: Increase to 7 mg once daily after 30 days
- Maximum dose: May increase to 14 mg once daily after at least 30 days on 7 mg, if additional control is required
How to Take Rybelsus
- Take first thing in the morning on an empty stomach
- Swallow whole with up to half a glass of plain water (no more than 120 mL)
- Do not split, crush, or chew the tablet
- Allow a minimum of 30 minutes to pass before consuming any food, beverages other than water, or other oral medications.
Missed Dose
If you miss a dose, do not take it later—simply skip it and continue with your next scheduled dose the next day. Do not take two doses to make up for a missed tablet.
Available Strengths
Rybelsus tablets are available in:
- 3 mg
- 7 mg
- 14 mg
Safety Information and Warnings
- Thyroid tumour risk: Do not use if you or a family member has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Pregnancy and breastfeeding: Not recommended; consult your clinician if pregnant or planning pregnancy
- Pancreatitis: Seek urgent care for persistent, severe abdominal pain
- Diabetic retinopathy: Monitor for visual changes if you have existing eye disease
Common Side Effects
- Nausea
- Diarrhoea
- Vomiting
- Constipation
- Reduced appetite
- Weight loss
Gastrointestinal effects are most common during dose escalation and often improve over time.
Using Rybelsus for Weight Management
Although primarily authorised for type 2 diabetes, Rybelsus is sometimes prescribed off-label for weight management. Higher doses (7 mg and 14 mg) are associated with greater appetite suppression. Always consult your prescriber before using semaglutide specifically for weight loss.
Rybelsus vs Ozempic
Both Rybelsus and Ozempic® injection contain semaglutide but differ in administration:
- Rybelsus: Oral tablet taken once daily
- Ozempic: Subcutaneous injection administered once weekly
Due to differences in absorption, there is no exact milligram-for-milligram equivalence between oral and injectable semaglutide. Clinical supervision is required when switching therapies.
Storage Instructions
- Store at room temperature
- Protect from moisture, heat and direct sunlight
- Keep out of reach of children and pets
Buying Rybelsus from LifePath Meds
Patients may purchase Rybelsus for personal use with through LifePath Meds. Many individuals choose this route due to price differences compared with other pharmacies, where a 30-day supply may exceed $700.
- Manufactured by Novo Nordisk
- Coupon code Hello10 offers 10% off first orders where eligible
- Direct-to-home shipping available
Always ensure compliance with FDA personal importation guidance (typically up to a 90-day supply).
Frequently Asked Questions
Is Rybelsus approved for weight loss?
Rybelsus is approved for type 2 diabetes management. Weight loss may occur as a secondary effect. Any off-label use should be reviewed and discussed with a qualified healthcare professional.
Can I switch from Ozempic to Rybelsus?
Switching may be possible depending on your current dose and timing. Your prescriber will guide dose selection and transition.
Is 14 mg equivalent to Ozempic 0.5 mg?
There is no direct equivalence due to differences in absorption. Some clinicians consider 14 mg roughly comparable to lower injectable doses, but individual response varies.
Can I lose 20 pounds in one month?
Rapid weight loss of this magnitude is uncommon and may not be safe. Sustainable weight reduction should be medically supervised.
How can I reduce the cost?
Manufacturer copay programmes may reduce eligible patients’ costs to as low as $10. Alternatively, purchasing through licensed Canadian suppliers may offer savings.
Consult Your Prescriber
- Discuss appropriate dosing before initiation
- Monitor blood glucose regularly
- Follow dietary and physical activity guidance
- Report side effects or medication interactions promptly



